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governing board and first core 
staff. All going well, the first 
knowledge communities will then 
be selected in 2009, and serious 
money will be pumped into 
research from 2010 onwards. 
So will this whole enterprise 
take funding away from other 
EU activities? The Commission 
has not presented a detailed 
financial plan yet. Apart from 
some EU funding, it will probably 
also expect contributions from 
the member states, most of 
which have so far failed to 
come near to the common goal 
of spending 3 per cent of GNP 
on research and development. 
Most crucially, however, the 
Commission emphasises that all 
the partnerships are expected 
to attract funding from private 
companies, large and small. It 
calls for “a new approach to 
funding” and for a new culture of 
mutual understanding between 
academic researchers and 
companies, including small and 
medium enterprises (SMEs) which 
may so far have lacked organised 
cooperation with universities. 
Thus, there would be some 
initial funding required to set up 
the governing board and core 
administration and to kick-start 
the research projects, but the 
underlying hope appears to be 
that, by raking in development 
funds from companies that would 
otherwise have looked to spend 
the money outside Europe, and 
by appealing to the conscience 
of under-spending member 
states, the EU will not have to 
commit much of its own budget 
on the EIT. 
Creating a world-class centre of 
excellence practically for free and 
reinforcing the knowledge triangle 
between education, research and 
innovation in the process — that 
sounds like another attempt to 
square the circle, and it may end 
up with the governments of the 
member states being at sixes and 
sevens with each other. Time will 
tell whether the EU got the maths 
right on this ambitious project 
for a new world-class technology 
institute. 
Michael Gross is a science writer based 
at Oxford. He can be contacted via his 
web page at www.proseandpassion.comThe European Commission last 
month finally lifted the ban on 
the export of British beef, as the 
number of cases of BSE in the 
country has fallen dramatically. 
But any relief felt by farmers has 
not yet moved through to those 
researching the human and other 
consequences of this devastating 
disease.
Scientific advisers to the 
EU Commission in Brussels 
signalled the end of the ban 
when they agreed that Britain’s 
anti-BSE measures had brought 
the disease to heel within 
its cattle population and its 
farmers should once more be 
allowed to compete for a share 
of international markets. The 
legislation needed to back up 
the recommendation could be in 
force later this month.
Markos Kyprianou, EU 
commissioner for health and 
consumer protection, said the 
commission “has taken no 
chances when it comes to dealing 
with BSE”, but Britain had made 
“great strides in tackling the 
disease, meeting all the necessary 
criteria.”
Cases of BSE are plummeting 
in the UK but fears continue for 
the wider impact. Nigel Williams 
reports.
BSE cloud lifts In Britain, the epidemic peaked in 1992, with over 36,000 cases 
confirmed, but since then the 
number of cases has declined 
dramatically. There have been only 
124 cases confirmed in animals 
born after the introduction of the 
reinforced ban in 1996. Overall 
the British epidemic is in steep 
decline with only 203 cases 
confirmed in 2005.
But there is little sign that 
the agenda for Spongiform 
Encephalopathy Advisory 
Committee (SEAC) and 
research teams is showing a 
concomitant tailing off. The 
committee monitors BSE and 
the other related spongiform 
encephalopathies including 
variant CJD, thought to derive 
from the BSE agent, and the 
sheep scrapie agent.
Since the introduction of new 
tests in 2002, around 100 cases 
of what is called atypical scrapie 
have been detected in sheep in 
the UK. These results have been 
highlighted as a continuing cause 
for concern. And the confirmation 
of another case of variant CJD 
through blood transfusion in 
February has led SEAC to step 
up the gathering of better data on 
the prevalence, age and genotype 
distribution, based on population 
studies of vCJD. These, it 
believes, “are required with some 
urgency”. These agents are still 
a threat to human and animal 
health.Beefing up: Cases of BSE are declining in the UK but wider worries about the agent 
remain. (Photo: Martyn Chillmaid/Oxford Scientific OSF.)
